Quantum BioPharma Stock Forward View
| QNTM Stock | 3.96 0.07 1.74% |
Quantum Stock outlook is based on your current time horizon. Although Quantum BioPharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Quantum BioPharma's systematic risk associated with finding meaningful patterns of Quantum BioPharma fundamentals over time.
As of now, the RSI of Quantum BioPharma's share price is approaching 34 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Quantum BioPharma, making its price go up or down. Momentum 34
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (3.44) | EPS Estimate Current Year (11.36) | EPS Estimate Next Year (5.16) | Wall Street Target Price 44.917 | EPS Estimate Current Quarter (3.70) |
Using Quantum BioPharma hype-based prediction, you can estimate the value of Quantum BioPharma from the perspective of Quantum BioPharma response to recently generated media hype and the effects of current headlines on its competitors.
Quantum Relative Strength Index
The Naive Prediction forecasted value of Quantum BioPharma on the next trading day is expected to be 2.24 with a mean absolute deviation of 0.62 and the sum of the absolute errors of 37.82.Quantum BioPharma Hype to Price Pattern
Investor biases related to Quantum BioPharma's public news can be used to forecast risks associated with an investment in Quantum. The trend in average sentiment can be used to explain how an investor holding Quantum can time the market purely based on public headlines and social activities around Quantum BioPharma. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Quantum BioPharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Quantum BioPharma.
The Naive Prediction forecasted value of Quantum BioPharma on the next trading day is expected to be 2.24 with a mean absolute deviation of 0.62 and the sum of the absolute errors of 37.82. Quantum BioPharma after-hype prediction price | USD 4.06 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Quantum BioPharma to cross-verify your projections. Quantum BioPharma Additional Predictive Modules
Most predictive techniques to examine Quantum price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Quantum using various technical indicators. When you analyze Quantum charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Quantum BioPharma Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Quantum BioPharma's financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2016-06-30 | Previous Quarter 1.5 M | Current Value 445.9 K | Quarterly Volatility 13.8 M |
Quantum BioPharma Naive Prediction Price Forecast For the 5th of February
Given 90 days horizon, the Naive Prediction forecasted value of Quantum BioPharma on the next trading day is expected to be 2.24 with a mean absolute deviation of 0.62, mean absolute percentage error of 0.68, and the sum of the absolute errors of 37.82.Please note that although there have been many attempts to predict Quantum Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Quantum BioPharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Quantum BioPharma Stock Forecast Pattern
| Backtest Quantum BioPharma | Quantum BioPharma Price Prediction | Research Analysis |
Quantum BioPharma Forecasted Value
In the context of forecasting Quantum BioPharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Quantum BioPharma's downside and upside margins for the forecasting period are 0.04 and 11.87, respectively. We have considered Quantum BioPharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Quantum BioPharma stock data series using in forecasting. Note that when a statistical model is used to represent Quantum BioPharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.7306 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.6199 |
| MAPE | Mean absolute percentage error | 0.083 |
| SAE | Sum of the absolute errors | 37.8167 |
Predictive Modules for Quantum BioPharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Quantum BioPharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Quantum BioPharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Quantum BioPharma After-Hype Price Density Analysis
As far as predicting the price of Quantum BioPharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Quantum BioPharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Quantum BioPharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Quantum BioPharma Estimiated After-Hype Price Volatility
In the context of predicting Quantum BioPharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Quantum BioPharma's historical news coverage. Quantum BioPharma's after-hype downside and upside margins for the prediction period are 0.20 and 13.70, respectively. We have considered Quantum BioPharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Quantum BioPharma is dangerous at this time. Analysis and calculation of next after-hype price of Quantum BioPharma is based on 3 months time horizon.
Quantum BioPharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Quantum BioPharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Quantum BioPharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Quantum BioPharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.84 | 9.64 | 0.50 | 0.00 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.96 | 4.06 | 0.74 |
|
Quantum BioPharma Hype Timeline
Quantum BioPharma is at this time traded for 3.96. The entity has historical hype elasticity of 0.5, and average elasticity to hype of competition of 0.0. Quantum is anticipated to increase in value after the next headline, with the price projected to jump to 4.06 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.74%, whereas the daily expected return is at this time at -0.84%. The volatility of related hype on Quantum BioPharma is about 482000.0%, with the expected price after the next announcement by competition of 3.96. Net Loss for the year was (14.92 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Historical Fundamental Analysis of Quantum BioPharma to cross-verify your projections.Quantum BioPharma Related Hype Analysis
Having access to credible news sources related to Quantum BioPharma's direct competition is more important than ever and may enhance your ability to predict Quantum BioPharma's future price movements. Getting to know how Quantum BioPharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Quantum BioPharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RVPH | Reviva Pharmaceuticals Holdings | (0.01) | 8 per month | 0.00 | (0.09) | 10.71 | (9.68) | 57.05 | |
| ANVS | Annovis Bio | (0.04) | 9 per month | 5.33 | 0.06 | 14.79 | (9.57) | 41.06 | |
| CPIX | Cumberland Pharmaceuticals | (0.01) | 20 per month | 4.85 | 0.06 | 12.60 | (7.76) | 27.96 | |
| PYPD | PolyPid | (0.08) | 9 per month | 1.80 | 0.12 | 4.79 | (3.95) | 13.02 | |
| RMTI | Rockwell Medical | (0.04) | 10 per month | 4.02 | 0.02 | 6.54 | (6.52) | 40.19 | |
| RNTX | Rein Therapeutics | 0.07 | 9 per month | 0.00 | (0.03) | 10.74 | (8.06) | 30.32 | |
| CELU | Celularity | (0.07) | 7 per month | 0.00 | (0.12) | 9.01 | (8.97) | 26.97 | |
| BCAB | Bioatla | 0.01 | 8 per month | 0.00 | (0.15) | 15.28 | (18.87) | 66.15 | |
| ATNM | Actinium Pharmaceuticals | 0.00 | 6 per month | 0.00 | (0.07) | 5.84 | (5.43) | 20.75 | |
| EVAX | Evaxion Biotech AS | 0.19 | 9 per month | 0.00 | (0.14) | 9.15 | (8.42) | 37.88 |
Other Forecasting Options for Quantum BioPharma
For every potential investor in Quantum, whether a beginner or expert, Quantum BioPharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Quantum Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Quantum. Basic forecasting techniques help filter out the noise by identifying Quantum BioPharma's price trends.Quantum BioPharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Quantum BioPharma stock to make a market-neutral strategy. Peer analysis of Quantum BioPharma could also be used in its relative valuation, which is a method of valuing Quantum BioPharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Quantum BioPharma Market Strength Events
Market strength indicators help investors to evaluate how Quantum BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Quantum BioPharma shares will generate the highest return on investment. By undertsting and applying Quantum BioPharma stock market strength indicators, traders can identify Quantum BioPharma entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 3.96 | |||
| Day Typical Price | 3.96 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.07) | |||
| Relative Strength Index | 34.75 |
Quantum BioPharma Risk Indicators
The analysis of Quantum BioPharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Quantum BioPharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting quantum stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.21 | |||
| Standard Deviation | 9.47 | |||
| Variance | 89.64 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Quantum BioPharma
The number of cover stories for Quantum BioPharma depends on current market conditions and Quantum BioPharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Quantum BioPharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Quantum BioPharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Quantum BioPharma Short Properties
Quantum BioPharma's future price predictability will typically decrease when Quantum BioPharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Quantum BioPharma often depends not only on the future outlook of the potential Quantum BioPharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quantum BioPharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 M | |
| Cash And Short Term Investments | 7.2 M |
Check out Historical Fundamental Analysis of Quantum BioPharma to cross-verify your projections. To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Will Biotechnology sector continue expanding? Could Quantum diversify its offerings? Factors like these will boost the valuation of Quantum BioPharma. Anticipated expansion of Quantum directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Quantum BioPharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Quantum BioPharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Quantum BioPharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Quantum BioPharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.